Azithromycin

Product NDC: 63187-093
11-digit product format: 631870093
Labeler code: 63187
Product ID: 63187-093_9d10dacc-ad17-48ec-b037-94987b2c40bc
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Azithromycin
Dosage form: POWDER, FOR SUSPENSION
Route: ORAL
Labeler: Proficient Rx LP
Application: ANDA065246
Marketing category: ANDA
Marketing start: 2010-12-17
Substance: AZITHROMYCIN MONOHYDRATE
Active strength: 200 mg/5mL
Pharmacologic classes: Macrolide Antimicrobial [EPC], Macrolides [CS]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 3 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Product NDC	Package NDC	Code	Status	Archive	Snapshot	Source SHA-256
2019-12-08 06:16 UTC · source 2019-12-05	excluded product	product	63187-093		E	Excluded after deficient or non-compliant submission was not corrected	excluded / ndc_excluded.zip	`110d247fa046…`	`a55b01930146…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded package	package	63187-093	63187-093-30	E	Excluded after deficient or non-compliant submission was not corrected	excluded / ndc_excluded.zip	`110d247fa046…`	`a55b01930146…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded package	package	63187-093	63187-093-15	E	Excluded after deficient or non-compliant submission was not corrected	excluded / ndc_excluded.zip	`110d247fa046…`	`a55b01930146…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A065246-001	AZITHROMYCIN	AZITHROMYCIN	EQ 200MG BASE/5ML	FOR SUSPENSION / ORAL	AB		2006-07-05
A065246-002	AZITHROMYCIN	AZITHROMYCIN	EQ 100MG BASE/5ML	FOR SUSPENSION / ORAL	AB		2006-07-05

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-product	TE code
A065246-001	AB
A065246-002	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A065246-001	AZITHROMYCIN	EQ 200MG BASE/5ML	FOR SUSPENSION / ORAL	AB	2006-07-05	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A065246-002	AZITHROMYCIN	EQ 100MG BASE/5ML	FOR SUSPENSION / ORAL	AB	2006-07-05	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065246-001	AZITHROMYCIN	EQ 200MG BASE/5ML	FOR SUSPENSION / ORAL	AB	2006-07-05	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065246-002	AZITHROMYCIN	EQ 100MG BASE/5ML	FOR SUSPENSION / ORAL	AB	2006-07-05	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A065246-001	AZITHROMYCIN	EQ 200MG BASE/5ML	FOR SUSPENSION / ORAL	AB	2006-07-05	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A065246-002	AZITHROMYCIN	EQ 100MG BASE/5ML	FOR SUSPENSION / ORAL	AB	2006-07-05	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065246-001	AZITHROMYCIN	EQ 200MG BASE/5ML	FOR SUSPENSION / ORAL	AB	2006-07-05	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065246-002	AZITHROMYCIN	EQ 100MG BASE/5ML	FOR SUSPENSION / ORAL	AB	2006-07-05	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065246-001	AZITHROMYCIN	EQ 200MG BASE/5ML	FOR SUSPENSION / ORAL	AB	2006-07-05	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065246-002	AZITHROMYCIN	EQ 100MG BASE/5ML	FOR SUSPENSION / ORAL	AB	2006-07-05	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065246-001	AZITHROMYCIN	EQ 200MG BASE/5ML	FOR SUSPENSION / ORAL	AB	2006-07-05	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065246-002	AZITHROMYCIN	EQ 100MG BASE/5ML	FOR SUSPENSION / ORAL	AB	2006-07-05	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065246-001	AZITHROMYCIN	EQ 200MG BASE/5ML	FOR SUSPENSION / ORAL	AB	2006-07-05	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065246-002	AZITHROMYCIN	EQ 100MG BASE/5ML	FOR SUSPENSION / ORAL	AB	2006-07-05	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065246-001	AZITHROMYCIN	EQ 200MG BASE/5ML	FOR SUSPENSION / ORAL	AB	2006-07-05	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065246-002	AZITHROMYCIN	EQ 100MG BASE/5ML	FOR SUSPENSION / ORAL	AB	2006-07-05	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065246-001	AZITHROMYCIN	EQ 200MG BASE/5ML	FOR SUSPENSION / ORAL	AB	2006-07-05	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065246-002	AZITHROMYCIN	EQ 100MG BASE/5ML	FOR SUSPENSION / ORAL	AB	2006-07-05	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A065246-001	AZITHROMYCIN	EQ 200MG BASE/5ML	FOR SUSPENSION / ORAL	AB	2006-07-05	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A065246-002	AZITHROMYCIN	EQ 100MG BASE/5ML	FOR SUSPENSION / ORAL	AB	2006-07-05	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065246-001	AZITHROMYCIN	EQ 200MG BASE/5ML	FOR SUSPENSION / ORAL	AB	2006-07-05	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065246-002	AZITHROMYCIN	EQ 100MG BASE/5ML	FOR SUSPENSION / ORAL	AB	2006-07-05	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A065246-001	AZITHROMYCIN	EQ 200MG BASE/5ML	FOR SUSPENSION / ORAL	AB	2006-07-05	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A065246-002	AZITHROMYCIN	EQ 100MG BASE/5ML	FOR SUSPENSION / ORAL	AB	2006-07-05	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A065246-001	AZITHROMYCIN	EQ 200MG BASE/5ML	FOR SUSPENSION / ORAL	AB	2006-07-05	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A065246-002	AZITHROMYCIN	EQ 100MG BASE/5ML	FOR SUSPENSION / ORAL	AB	2006-07-05	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A065246-001	AZITHROMYCIN	EQ 200MG BASE/5ML	FOR SUSPENSION / ORAL	AB	2006-07-05	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A065246-002	AZITHROMYCIN	EQ 100MG BASE/5ML	FOR SUSPENSION / ORAL	AB	2006-07-05	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A065246-001	AZITHROMYCIN	EQ 200MG BASE/5ML	FOR SUSPENSION / ORAL	AB	2006-07-05	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A065246-002	AZITHROMYCIN	EQ 100MG BASE/5ML	FOR SUSPENSION / ORAL	AB	2006-07-05	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A065246-001	AZITHROMYCIN	EQ 200MG BASE/5ML	FOR SUSPENSION / ORAL	AB	2006-07-05	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A065246-002	AZITHROMYCIN	EQ 100MG BASE/5ML	FOR SUSPENSION / ORAL	AB	2006-07-05	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A065246-001	AZITHROMYCIN	EQ 200MG BASE/5ML	FOR SUSPENSION / ORAL	AB	2006-07-05	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A065246-002	AZITHROMYCIN	EQ 100MG BASE/5ML	FOR SUSPENSION / ORAL	AB	2006-07-05	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A065246-001	AZITHROMYCIN	EQ 200MG BASE/5ML	FOR SUSPENSION / ORAL	AB	2006-07-05	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A065246-002	AZITHROMYCIN	EQ 100MG BASE/5ML	FOR SUSPENSION / ORAL	AB	2006-07-05	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A065246-001	AZITHROMYCIN	EQ 200MG BASE/5ML	FOR SUSPENSION / ORAL	AB	2006-07-05	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A065246-002	AZITHROMYCIN	EQ 100MG BASE/5ML	FOR SUSPENSION / ORAL	AB	2006-07-05	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A065246-001	AZITHROMYCIN	EQ 200MG BASE/5ML	FOR SUSPENSION / ORAL	AB	2006-07-05	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A065246-002	AZITHROMYCIN	EQ 100MG BASE/5ML	FOR SUSPENSION / ORAL	AB	2006-07-05	`782e0a99824c…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A065246-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A065246-002	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065246-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065246-002	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A065246-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A065246-002	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065246-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065246-002	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065246-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065246-002	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065246-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065246-002	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065246-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065246-002	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065246-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065246-002	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065246-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065246-002	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A065246-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A065246-002	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065246-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065246-002	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A065246-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A065246-002	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A065246-001	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A065246-002	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A065246-001	AB	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A065246-002	AB	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A065246-001	AB	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A065246-002	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A065246-001	AB	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A065246-002	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A065246-001	AB	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A065246-002	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A065246-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A065246-002	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A065246-001	AB	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A065246-002	AB	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A065246-001	AB	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A065246-002	AB	1	`782e0a99824c…`

Additional Listing Data#

Finished product: Yes
Brand name base: Azithromycin
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
AZITHROMYCIN MONOHYDRATE	200 mg/5mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
JTE4MNN1MD	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
141963	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
44134421-cb0b-4e85-a3c8-d58bdb476fad	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
bc5cb41f-7cc8-4f57-b1a7-5eaf0458a401	Product name	9	20200616
a2cbe82e-b432-4f71-954b-75e9214e8567	Product name	3	20200612
371533fa-efb3-4c48-b5e4-60179db407f3	Product name	3	20190124

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
63187-093-15	Azithromycin	15 mL in 1 BOTTLE	POWDER, FOR SUSPENSION	15	6
63187-093-22	Azithromycin	22.5 mL in 1 BOTTLE	POWDER, FOR SUSPENSION	22.5	6
63187-093-30	Azithromycin	30 mL in 1 BOTTLE	POWDER, FOR SUSPENSION	30	6

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
63187-093-22	ML - Milliliter	63187-093	a9ce2f12-b4c9-41fb-9845-cfb46d4853b3	1	2024-06-10

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
AZITHROMYCIN MONOHYDRATE	ACTIVE INGREDIENT	JTE4MNN1MD	AZITHROMYCIN POWDER, FOR SUSPENSION [PROFICIENT RX LP]	3
AZITHROMYCIN ANHYDROUS	ACTIVE MOIETY	J2KLZ20U1M	AZITHROMYCIN POWDER, FOR SUSPENSION [PROFICIENT RX LP]	3
DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER	INACTIVE INGREDIENT	905HNO1SIH	AZITHROMYCIN POWDER, FOR SUSPENSION [PROFICIENT RX LP]	3
FD&C RED NO. 40	INACTIVE INGREDIENT	WZB9127XOA	AZITHROMYCIN POWDER, FOR SUSPENSION [PROFICIENT RX LP]	3
HYDROXYPROPYL CELLULOSE (TYPE H)	INACTIVE INGREDIENT	RFW2ET671P	AZITHROMYCIN POWDER, FOR SUSPENSION [PROFICIENT RX LP]	3
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	AZITHROMYCIN POWDER, FOR SUSPENSION [PROFICIENT RX LP]	3
SODIUM PHOSPHATE, TRIBASIC, ANHYDROUS	INACTIVE INGREDIENT	SX01TZO3QZ	AZITHROMYCIN POWDER, FOR SUSPENSION [PROFICIENT RX LP]	3
SUCROSE	INACTIVE INGREDIENT	C151H8M554	AZITHROMYCIN POWDER, FOR SUSPENSION [PROFICIENT RX LP]	3
XANTHAN GUM	INACTIVE INGREDIENT	TTV12P4NEE	AZITHROMYCIN POWDER, FOR SUSPENSION [PROFICIENT RX LP]	3

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
63187-093	AZITHROMYCIN POWDER, FOR SUSPENSION [PROFICIENT RX LP]	6	Current NDC, Legacy NDC, 3 package rows	20240412_44134421-cb0b-4e85-a3c8-d58bdb476fad.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 6 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Azithromycin	AZITHROMYCIN	Preferred Pharmaceuticals Inc.	ac327054-21ab-401c-a27a-48259db18f89	2026-03-11	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065246 application number: ANDA065246
Azithromycin	AZITHROMYCIN	A-S Medication Solutions	f97d2e7e-ccfd-4f04-85ba-549b37f6aa7b	2024-07-22	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065246 application number: ANDA065246
Azithromycin	AZITHROMYCIN	NuCare Pharmaceuticals,Inc.	549cdd0a-da79-23b8-e054-00144ff8d46c	2024-07-17	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065246 application number: ANDA065246
Azithromycin	AZITHROMYCIN	Proficient Rx LP	44134421-cb0b-4e85-a3c8-d58bdb476fad	2024-04-01	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065246 application number: ANDA065246 ndc (product): 63187-093
Azithromycin	AZITHROMYCIN	STATE HEALTH SERVICES, TEXAS DEPARTMENT OF	2b821631-0df2-0fb2-e054-00144ff8d46c	2024-02-29	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065246 application number: ANDA065246
Azithromycin	AZITHROMYCIN	Teva Pharmaceuticals USA, Inc.	3209b147-11ce-4eeb-8427-5f8e6fb2c83d	2022-07-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065246 application number: ANDA065246

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
JTE4MNN1MD	AZITHROMYCIN MONOHYDRATE	121470-24-4	AZITHROMYCIN MONOHYDRATE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
141963	azithromycin 200 MG in 5 mL Oral Suspension	PSN	44134421-cb0b-4e85-a3c8-d58bdb476fad	6
141963	azithromycin 40 MG/ML Oral Suspension	SCD	44134421-cb0b-4e85-a3c8-d58bdb476fad	6
141963	azithromycin 1200 MG per 30 ML Oral Suspension	SY	44134421-cb0b-4e85-a3c8-d58bdb476fad	6
141963	azithromycin 200 MG per 5 ML Oral Suspension	SY	44134421-cb0b-4e85-a3c8-d58bdb476fad	6
141963	azithromycin 600 MG per 15 ML Oral Suspension	SY	44134421-cb0b-4e85-a3c8-d58bdb476fad	6

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
63187-093-15	63187009315	15 mL in 1 BOTTLE (63187-093-15)	15 ml	2014-07-01	0000-00-00	No	No	Current
63187-093-22	63187009322	22.5 mL in 1 BOTTLE (63187-093-22)	22.5 ml	2024-04-03		No	No	Current
63187-093-30	63187009330	30 mL in 1 BOTTLE (63187-093-30)	30 ml	2014-07-01	0000-00-00	No	No	Current